Jun 09, 2022 / 06:30PM GMT
Peter James Welford - Jefferies LLC, Research Division - Senior Equity Analyst & European Pharmaceuticals Analyst
Okay. Thank you all. We'll get started. My name is Peter Welford. I'm the European pharma and biotech analyst at Jefferies in London. It's my great pleasure to introduce the next company, which is obviously Sanofi. And here today, we have John Reed, who is the Head of R&D.
It's a fireside chat. If anyone in the audience does have any questions, by all means, raise your hand. And I think we've got a mic out there; we can try and get to you. Apologies, we can't actually see you very much, so you might jump up and down as well.
But with that, we'll get started. So right John, let's start off.
John C. Reed - Sanofi - Executive VP and Global Head of Research & Development
Can I first say that given how cold it is in here, I wish we did have a fire? This is amazing, yes. But anyway, okay.
Sanofi SA at Jefferies Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers